Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York

Thomas J. Simra; Don C. Des Jareais; Michael Marmor; Stanley Yancovitz; Samuel Friedman; Jonathan Garber; Henry Cohen; Ciril Cabradilla; V. C. Kaiyanaraman

doi:10.1056/NEJM198408163110712

Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York

Thomas J. Simra, Don C. Des Jareais, Michael Marmor, Stanley Yancovitz, Samuel Friedman, Jonathan Garber, Henry Cohen, Ciril Cabradilla, V. C. Kaiyanaraman

Global Public Health

Research output: Contribution to journal › Letter › peer-review

Abstract

To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.¹ Lymphadcnopathy-associatcd virus² and human T-ccll lymphotropic virus III³ are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS. Scrum specimens were collected from 86 intravenous-drug.

Original language	English (US)
Pages (from-to)	467-468
Number of pages	2
Journal	New England Journal of Medicine
Volume	311
Issue number	7
DOIs	https://doi.org/10.1056/NEJM198408163110712
State	Published - Aug 16 1984

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM198408163110712

Cite this

@article{f54be49a9c974f5aad1899f8f346d899,

title = "Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York",

abstract = "To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.1 Lymphadcnopathy-associatcd virus2 and human T-ccll lymphotropic virus III3 are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS. Scrum specimens were collected from 86 intravenous-drug.",

author = "Simra, {Thomas J.} and {Des Jareais}, {Don C.} and Michael Marmor and Stanley Yancovitz and Samuel Friedman and Jonathan Garber and Henry Cohen and Ciril Cabradilla and Kaiyanaraman, {V. C.}",

year = "1984",

month = aug,

day = "16",

doi = "10.1056/NEJM198408163110712",

language = "English (US)",

volume = "311",

pages = "467--468",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York

AU - Simra, Thomas J.

AU - Des Jareais, Don C.

AU - Marmor, Michael

AU - Yancovitz, Stanley

AU - Friedman, Samuel

AU - Garber, Jonathan

AU - Cohen, Henry

AU - Cabradilla, Ciril

AU - Kaiyanaraman, V. C.

PY - 1984/8/16

Y1 - 1984/8/16

N2 - To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.1 Lymphadcnopathy-associatcd virus2 and human T-ccll lymphotropic virus III3 are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS. Scrum specimens were collected from 86 intravenous-drug.

AB - To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.1 Lymphadcnopathy-associatcd virus2 and human T-ccll lymphotropic virus III3 are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS. Scrum specimens were collected from 86 intravenous-drug.

UR - http://www.scopus.com/inward/record.url?scp=0021615218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021615218&partnerID=8YFLogxK

U2 - 10.1056/NEJM198408163110712

DO - 10.1056/NEJM198408163110712

M3 - Letter

C2 - 6087140

AN - SCOPUS:0021615218

SN - 0028-4793

VL - 311

SP - 467

EP - 468

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this